How to Avoid Patent Cliffs: Product Hopping in the Pharma Sector

In May 2015, Mylan Pharmaceuticals appealed to the Third Circuit after the lower court dismissed its case against … Continue Reading

EU’s Approach to Bans on Online Sales: Consumer Welfarism or Digital Market Integration?

The European Commission has stated that transforming the EU into a single digital market — that is, removing … Continue Reading

US v. EU: Pay-for-delay Settlements

Reverse payment settlements exist at the intersection among¬†antitrust, patent and healthcare laws. Also known as pay-for-delay agreements, these … Continue Reading

Withdrawal of Rights from Performing Rights Organizations: In re Pandora

In re Pandora is the most recent battle between Performing Rights Organizations (“PROs”) and an internet radio service … Continue Reading

Google and the Sherman Act or: How I Learned to Stop Worrying and Love Civil Procedure

Overview Google’s market dominance has attracted the attention of the press, competitors, and now the federal government. Recent … Continue Reading